Rockefeller Capital Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
+106
New +$6.94K ﹤0.01% 3967
2023
Q1
– Sell
-1
Closed – – 2008
2022
Q4
$0 Sell
1
-30
-97% -$14.1K ﹤0.01% 3818
2022
Q3
$18K Sell
31
-11
-26% -$6.59K ﹤0.01% 2810
2022
Q2
$22K Buy
42
+7
+20% +$3.54K ﹤0.01% 2681
2022
Q1
$21K Buy
35
+28
+400% +$14.4K ﹤0.01% 2691
2021
Q4
$4K Buy
+7
New +$4.26K ﹤0.01% 3322

Other funds holding AGL

Rockefeller Capital Management's AGL Position: Q2 2026 in Review

Rockefeller Capital Management opened a new position in Agilon Health (AGL) in Q2 2026: 106 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #3967 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in AGL as recently as Q4 2022.

Rockefeller Capital Management first reported a position in AGL in Q4 2021 and has held it in 6 quarters since. The position peaked at $22K in Q2 2022. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Rockefeller Capital Management held 106 shares of Agilon Health worth $11.4K as of Q2 2026.
  • Agilon Health was a new Rockefeller Capital Management position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3967 holding.
  • Rockefeller Capital Management first reported a position in Agilon Health in Q4 2021 and has held it in 6 quarters since.
  • Rockefeller Capital Management's Agilon Health position peaked at $22K in Q2 2022.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.